Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TUP
6626
CALL
DELISTED
Tupperware Brands Corporation
TUP
| $1.14M | ﹤0.01% |
180,200
-186,400
| -51% | -$2.08M |
|
|
BRT
6627
CALL
BRT Apartments
BRT
$271M
| $1.14M | ﹤0.01% |
53,100
+19,300
| +57% | +$425K |
|
6628
PUT
Teucrium Corn Fund
CORN
$169M
| $1.14M | ﹤0.01% |
45,300
-172,600
| -79% | -$4.93M |
|
|
RDUS
6629
CALL
DELISTED
Radius Recycling
RDUS
| $1.14M | ﹤0.01% |
34,700
-12,500
| -26% | -$533K |
|
|
SHCR
6630
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $1.14M | ﹤0.01% |
720,381
-309,638
| -30% | -$760K |
|
|
PIAI
6631
DELISTED
Prime Impact Acquisition I
PIAI
| $1.14M | ﹤0.01% |
113,944
-21,174
| -16% | -$210K |
|
6632
Schwab US REIT ETF
SCHH
$11.4B
| $1.14M | ﹤0.01% |
+53,970
| New | +$1.24M |
|
6633
CALL
Sundial Growers
SNDL
$308M
| $1.14M | ﹤0.01% |
348,610
-40,220
| -10% | -$178K |
|
|
SILK
6634
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.14M | ﹤0.01% |
31,250
-175,070
| -85% | -$6.36M |
|
|
CCXI
6635
PUT
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.14M | ﹤0.01% |
45,900
-95,000
| -67% | -$2.09M |
|
6636
VistaGen Therapeutics
VTGN
$11.8M
| $1.14M | ﹤0.01% |
43,033
+8,206
| +24% | +$290K |
|
6637
CALL
Bakkt Inc
BKKT
$317M
| $1.14M | ﹤0.01% |
21,628
-12,980
| -38% | -$1.09M |
|
6638
CALL
Compass Diversified
CODI
$908M
| $1.14M | ﹤0.01% |
53,000
+5,900
| +13% | +$134K |
|
6639
PUT
Itaú Unibanco
ITUB
$81.2B
| $1.14M | ﹤0.01% |
300,472
-91,093
| -23% | -$405K |
|
|
LX
6640
LexinFintech Holdings
LX
$221M
| $1.14M | ﹤0.01% |
508,809
+127,495
| +33% | +$295K |
|
6641
Tompkins Financial
TMP
$1.44B
| $1.13M | ﹤0.01% |
+15,719
| New | +$1.16M |
|
|
CCMP
6642
CALL
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $1.13M | ﹤0.01% |
6,500
-9,400
| -59% | -$1.67M |
|
6643
CALL
Beam Global
BEEM
$24M
| $1.13M | ﹤0.01% |
73,000
-4,600
| -6% | -$79.2K |
|
6644
CALL
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.08B
| $1.13M | ﹤0.01% |
9,070
+7,810
| +620% | +$1.08M |
|
6645
PUT
B2Gold
BTG
$6.66B
| $1.13M | ﹤0.01% |
333,800
+73,100
| +28% | +$305K |
|
6646
PUT
Iovance Biotherapeutics
IOVA
$3.19B
| $1.13M | ﹤0.01% |
102,500
-98,100
| -49% | -$1.29M |
|
|
IBHC
6647
DELISTED
iShares iBonds 2023 Term High Yield and Income ETF
IBHC
| $1.13M | ﹤0.01% |
+48,381
| New | +$1.14M |
|
|
DEA
6648
PUT
Easterly Government Properties
DEA
$1.17B
| $1.13M | ﹤0.01% |
23,760
+12,920
| +119% | +$630K |
|
6649
PUT
Hess Midstream
HESM
$5.12B
| $1.13M | ﹤0.01% |
40,400
-32,400
| -45% | -$1,000K |
|
6650
Amplitude
AMPL
$1.59B
| $1.13M | ﹤0.01% |
79,127
-526,740
| -87% | -$9.24M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.